Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FERM and PDZ domain-containing protein 2 (FRMPD2) is a multi-domain peripheral membrane protein found predominantly in epithelial cells[1][2][3][4]. Its structure comprises an N-terminal KIND (Kinase non-catalytic C-lobe domain), a FERM (Four-point-one, ezrin, radixin, moesin) domain responsible for membrane localization, and three PDZ domains essential for targeting to junctional regions and scaffolding functions[1][3]. The protein is recruited to cell-cell junctions in an E-cadherin-dependent manner and is selectively localized at the basolateral membrane in polarized epithelial cells[1][2]. It interacts with catenin family members (such as δ-catenin, p0071, and ARVCF) through its PDZ domains, supporting tight junction formation and possibly influencing cell polarity[1]. FRMPD2 may also play a role in synapse formation and immune signaling, but these roles are less clearly established[3][4]. Disease associations are limited, mainly involving rare genetic syndromes or conditions linked to cell junction integrity and polarity[3]. No drugs or biomarkers targeting FRMPD2 are known, and it is not classified as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FERM and PDZ domain-containing protein 2 (FRMPD2).